<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Activation-induced <z:chebi fb="0" ids="17562">cytidine</z:chebi> deaminase (AID) induces <z:hpo ids='HP_0001428'>somatic mutations</z:hpo> in various host genes of non-lymphoid tissues, thereby contributing to <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>We recently demonstrated that <z:hpo ids='HP_0005202'>Helicobacter pylori infection</z:hpo> and/or proinflammatory cytokine stimulation triggers aberrant AID expression in gastric epithelial cells, causing mutations in the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e>-suppressor TP53 gene </plain></SENT>
<SENT sid="2" pm="."><plain>The findings of the present study provide evidence of ectopic AID expression in <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> and Barrett's oesophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp>, a <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> that develops under <z:hpo ids='HP_0011010'>chronic</z:hpo> inflammatory conditions </plain></SENT>
<SENT sid="3" pm="."><plain>Immunoreactivity for endogenous AID was observed in 24 of 28 (85.7%) specimens of the columnar cell-lined <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> and in 20 of 22 (90.9%) of Barrett's <z:mp ids='MP_0009308'>adenocarcinoma</z:mp>, whereas weak or no AID protein expression was detectable in <z:mpath ids='MPATH_458'>normal</z:mpath> squamous epithelial cells of the oesophagus </plain></SENT>
<SENT sid="4" pm="."><plain>We validated these results by analysing tissue specimens from another cohort comprising 16 cases with <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> and four cases with Barrett's <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>In vitro treatment of human non-neoplastic oesophageal squamous-derived cells with <z:chebi fb="8" ids="26714">sodium salt</z:chebi> <z:chebi fb="0" ids="28834">deoxycholic acid</z:chebi> induced ectopic AID expression via the nuclear factor-kappaB activation pathway </plain></SENT>
<SENT sid="6" pm="."><plain>These findings suggest that aberrant AID expression occurs in a substantial proportion of Barrett's epithelium, at least in part due to <z:chebi fb="0" ids="3098">bile acid</z:chebi> stimulation </plain></SENT>
<SENT sid="7" pm="."><plain>Considering the genotoxic activity of AID, our current findings suggest that aberrant AID expression might enhance the susceptibility to genetic alterations in Barrett's columnar-lined epithelial cells, leading to <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> development </plain></SENT>
</text></document>